Clinical trials recruiting in Bogota, D.C., Colombia
3
Recruiting trials
5
Conditions
Phase breakdown
Phase 3 3
Conditions recruiting in Bogota, D.C., Colombia
| Condition | Trials |
|---|---|
| Breast cancer | 2 |
| Crohn's disease | 1 |
| Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer | 1 |
| Metastatic Breast Cancer | 1 |
| Moderately to Severely Active Crohns Disease | 1 |
Recruiting trials in Bogota, D.C., Colombia
- A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
- A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
- A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Common questions
How many clinical trials are recruiting in Bogota, D.C., Colombia?
3 recruiting trials have at least one study site in Bogota, D.C., Colombia.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.